Publication | Closed Access

High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: Unusual toxicity and promising early results

Adaptive RadiotherapyRadiation TherapyMedicineConcurrent BoostUnusual ToxicityEarly ResultsCombined Modality TreatmentRadiation Therapy PlanningOncologyRadiation OncologyLung CancerRadiologyHealth Sciences